A Pause to Say "Thank You"
An ESUN Article
We published our first issue of ESUN in February 2004, five and half years ago. I think it is important at this point to step back and say "thank you" to everyone involved in this publication.
Many of you may not be aware of who are members of our board and staff. They are listed below. Each member of our Medical Editorial and Advisory Board, all extremely busy physicians, has given freely of their time to review articles that have been submitted for consideration for publication. In addition, many of them have written articles and Op Ed pieces for ESUN.
We have also enlisted the assistance of over 100 sarcoma oncologists worldwide in our peer-review process. They have taken time out of their schedules to send us detailed comments about the submissions we receive. Scores of sarcoma patients, caregivers, and survivors have also commented on submissions. ESUN has benefitted from an untold number of hours over this period of time from the Editorial Staff, Contributing Editors, and Copy Editors – all volunteers who have been affected by sarcoma.
There is, however, a particular volunteer that I must single out for extraordinary contributions to our efforts – our Associate Editor, Mary Sorens, who is an osteosarcoma survivor. She not only completely redesigned our website earlier this year to make the contents of ESUN more accessible and useful, but she also completely redesigned our clinical trials abstracts and search engine process, making this a truly useful facility. She has done all of this while being the inspiration and leading light of the online Adult Bone Cancer Survivors group, a time consuming commitment in its own right. Moreover, she has had an integral role in the Team Sarcoma Initiative (i.e., the International Sarcoma Awareness Week) in the past few years, helping it grow to over 8,000 people worldwide last year.
"Thank you" for everything you are doing for the sarcoma community is insufficient. Mary, we are in your debt.
Bruce
Medical Editorial and Advisory Board
Karen Albritton, MD, Dana-Farber Cancer Institute
Laurence Baker, DO, Southwest Oncology Group and SARC
Jean-Yves Blay, MD, PhD, Université Claude Bernard in Lyon, France
Murray Brennan, MD, Memorial Sloan-Kettering Cancer Center
Ernest "Chappie" Conrad, MD, University of Washington Medical Center
Mark Gebhardt, MD, Harvard University, Beth Israel Deaconess Medical Center
Richard Gorlick, MD, The Children's Hospital at Montefiore
Mary Louise Keohan, MD, Memorial Sloan-Kettering Cancer Center
Crystal Mackall, MD, National Cancer Institute
Ole Steen Nielsen, MD, University of Aarhus in Aarhus, Denmark
Raphael Pollock, MD, PhD, University of Texas M. D. Anderson Cancer Center
R. Lor Randall, MD, University of Utah, Huntsman Cancer Institute
Luca Sangiorgi, MD, PhD, Rizzoli Orthopaedic Institute (IOR), Italy
Leonard Wexler, MD, Memorial Sloan-Kettering Cancer Center
Sarcoma Advocacy Advisory Committee
MiMi Olsson
Mary Porcher Sorens
Editor-in-Chief
Associate Editor
Editorial Staff
Clinical Trials: Tom Swartz
Odds and Ends: Tom Swartz, Elizabeth Goldstein-Rice, and MiMi Olsson
Our Initiatives: Bruce Shriver, PhD
Stories of Courage and Hope: Tom Swartz, Elizabeth Goldstein-Rice, and MiMi Olsson
Research Corner: Bruce Shriver, PhD and Tom Swartz
Contributing Editors
Coordinating Editor, CTOS Op Ed: G. Douglas Letson, MD, Moffitt Cancer Center
From A Nurse's Perspective: Marianne Griffin, RN, BA
Participatory Medicine: Gilles Frydman
Copy Editors
Beverly Shriver, RN
Tom Swartz
V6N3 ESUN Copyright © 2009 Liddy Shriver Sarcoma Initiative.